График акции Palatin Technologies, Inc.
Расширенный график
Простой график
О компании Palatin Technologies, Inc.
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that has completed Phase I clinical trial for the treatment of inflammatory bowel diseases. подробнее| IPO date | 1993-10-28 |
|---|---|
| ISIN | US6960775020 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://palatin.com |
| Цена ао | 0.7218 |
| Изменение цены за день: | 0% (0.2053) |
|---|---|
| Изменение цены за неделю: | -53.55% (0.442) |
| Изменение цены за месяц: | -74.66% (0.8101) |
| Изменение цены за 3 месяца: | -80.99% (1.08) |
| Изменение цены за полгода: | -79.47% (1) |
| Изменение цены за год: | -89.19% (1.9) |
| Изменение цены за 3 года: | -54.38% (0.45) |
| Изменение цены за 5 лет: | -48.68% (0.4) |
| Изменение цены с начала года: | -79.26% (0.99) |
|
|
Недооценка
|
Эффективность
|
|||||||||||||||||||||||||||||||||||||
Дивиденды
|
Долг
|
Импульс роста
|
|||||||||||||||||||||||||||||||||||||
| Институционалы | Объем | Доля, % |
|---|---|---|
| Armistice Capital, LLC | 590000 | 3.66 |
| Vanguard Group Inc | 548622 | 3.4 |
| LPL Financial LLC | 146396 | 0.91 |
| Blackrock Inc. | 119518 | 0.74 |
| Geode Capital Management, LLC | 94148 | 0.58 |
| State Street Corporation | 30295 | 0.19 |
| Susquehanna International Group, LLP | 30062 | 0.19 |
| Bridgeway Capital Management, Inc. | 26124 | 0.16 |
| Northern Trust Corporation | 25097 | 0.16 |
| Montis Financial, LLC | 20964 | 0.13 |
| Руководитель | Должность | Оплата | Год рождения |
|---|---|---|---|
| Dr. Carl Spana Ph.D. | Co-Founder, President, CEO & Director | 979k | 1962 (63 года) |
| Mr. Stephen T. Wills CPA, MST | CFO, COO, Executive VP, Treasurer & Secretary | 910.55k | 1957 (68 лет) |
| Burns McClellan | Vice President of Investor Relations | N/A | |
| Mr. Stephen A. Slusher Esq. | Chief Legal Officer | N/A | |
| Dr. Michael B. Raizman M.D. | Chief Medical Officer | N/A | |
| Mr. James E. Hattersley | Senior Vice President of Business Development | N/A | 1960 (65 лет) |
| Mr. John Dodd Ph.D. | Senior Vice President of Preclinical Development | N/A | |
| Mr. Robert Jordan | Senior Vice President of Program Operations | N/A |
Адрес: United States, Cranbury. NJ, Cedar Brook Corporate Center - открыть в Google картах, открыть Яндекс картах
Сайт: https://palatin.com
Сайт: https://palatin.com
